Stock OCULUS INNOVATIVE SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Oculus Innovative Sciences, Inc. Nasdaq

Equities

US67575P2074

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Oculus Innovative Sciences, Inc.
09/07 Sonoma Pharmaceuticals, Inc. Announces New Distributor in Ukraine CI
17/06 Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Business Summary

Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.

Sales per Business

USD in Million2023Weight2024Weight Delta
Human Care
79.4 %
9 71.0 % 10 79.4 % +7.26%
Animal Care
17.3 %
3 18.8 % 2 17.3 % -11.88%
Service/Royalty
3.3 %
1 10.1 % 0 3.3 % -68.65%

Sales per region

USD in Million2023Weight2024Weight Delta
Europe
37.5 %
4 30.5 % 5 37.5 % +18.02%
United States
24.0 %
3 25.8 % 3 24.0 % -10.79%
Asia
18.0 %
2 18.5 % 2 18.0 % -6.24%
Latin America
13.6 %
2 18.0 % 2 13.6 % -27.57%
Rest of the World
6.8 %
1 7.2 % 1 6.8 % -9.07%

Managers

Managers TitleAgeSince
Amy Trombly CEO
 Chief Executive Officer 57 27/19/27
John Poggetto DFI
 Director of Finance/CFO 72 01/02/01
Jerome Dvonch DFI
 Director of Finance/CFO 56 08/20/08
Bruce Thornton COO
 Chief Operating Officer 59 01/04/01

Members of the board

Members of the board TitleAgeSince
Amy Trombly CEO
 Chief Executive Officer 57 27/19/27
Jay Birnbaum BRD
 Director/Board Member 79 20/07/20
Philippe Weigerstorfer BRD
 Director/Board Member 64 19/18/19
John Mclaughlin BRD
 Director/Board Member 76 01/13/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,004,393 18,600,648 ( 97.88 %) 0 97.88 %

Shareholders

NameEquities%Valuation
Bruce Thornton
0.8125 %
154,411 0.8125 % 32 735 $
Amy Trombly
0.8082 %
153,586 0.8082 % 32 560 $
Jerome Dvonch
0.4451 %
84,595 0.4451 % 17 934 $
G1 Execution Services LLC
0.2423 %
46,052 0.2423 % 9 763 $
Geode Capital Management LLC
0.1883 %
35,780 0.1883 % 7 585 $
STATE STREET CORPORATION
0.1279 %
24,315 0.1279 % 5 155 $
XTX Topco Ltd.
0.0866 %
16,463 0.0866 % 3 490 $
John dal Poggetto
0.0789 %
15,000 0.0789 % 3 180 $
Two Sigma Securities LLC
0.0709 %
13,473 0.0709 % 2 856 $
Millennium Management LLC
0.0685 %
13,016 0.0685 % 2 759 $

Company contact information

Sonoma Pharmaceuticals, Inc.

5445 Conestoga Court Suite 150

80301, Boulder

+800 759 9305

http://www.sonomapharma.com
address Oculus Innovative Sciences, Inc.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.35% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.64% 597B
JOHNSON & JOHNSON Stock Johnson & Johnson
-0.10% 377B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.47% 319B
ABBVIE INC. Stock AbbVie Inc.
+13.10% 310B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.51% 247B
NOVARTIS AG Stock Novartis AG
+16.72% 228B
AMGEN INC. Stock Amgen Inc.
+16.54% 180B
PFIZER, INC. Stock Pfizer, Inc.
+4.31% 170B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SNOA Stock
  4. Stock
  5. Company Oculus Innovative Sciences, Inc.